ClinicalTrials.gov
public full text
Public Domain
Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers
The purpose of this study is to evaluate the bactericidal activity against Mycobacterium tuberculosis of celecoxib in combination with established drugs used to treat tuberculosis (TB). Pharmacokinetics (PK) and whole blood bactericidal activity (WBA) will be measured in healthy volunteers following administration of the study drugs alone and in combination.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Development of novel bioanalytical assays and an objective adherence measure of key second-line tuberculosis drugs#666629
- Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines#125921
- Linezolid Dosing Strategies in Drug-Resistant TB#810954
- Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis#28392
- Evaluation of Centralised TB Assay Solutions#1126083
Record · ID 830964
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive